Viva Biotech
Shanghaivivabiotech.com
Overview
Viva Biotech is a global biopharmaceutical service and investment firm that provides integrated drug discovery and development services while operating a unique equity-for-service (EFS) investment model to support early-stage biotech startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HAYA Therapeutics | May 2025 | Series A | - |
| Antag Therapeutics | Dec 2024 | Series A | - |
| Full-Life Technologies | Jan 2024 | Series B | - |
| Mediar Therapeutics | Mar 2023 | Series A | - |
| TJ Biopharma | Jul 2022 | Series B | Co-investor |
Key People
Yinghong Gao
Venture Partner & VP of BD
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
